Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-2 of 2
Keywords: Biotechnology
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
The value relevance of accounting variables and analysts’ forecasts: The case of biotechnology firms
Journal:
Review of Accounting and Finance
Review of Accounting and Finance (2007) 6 (3): 233–253.
Published: 14 August 2007
... enhance our understanding on the determinants of the market value of biotech stocks. Originality/value This paper provides insights into the valuation of biotechnology stocks. Results show non‐linearities in the pricing of summary accounting measures and fundamental income statement variables...
Journal Articles
Journal:
Review of Accounting and Finance
Review of Accounting and Finance (2006) 5 (1): 59–71.
Published: 01 January 2006
.... Research and development Share prices Biotechnology Investments Economic fluctuations The rapid growth in the biotech industry increasingly attracts investors. For instance, this industry raised more than $15 billion in new capital in 2003 (Weintraub, 2004). However, new drugs take an average...
